OncoLize
PrivateLast Round
Seed
Apr 14, 2023
Total Funding Raised
$1.7M
Company Overview
OncoLize is a biopharmaceutical company that develops injectable drug depots for localized and controlled delivery of drugs inside tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoLize Comparables
Compare OncoLize with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TargTex | 79% | |
| SURGE Therapeutics | 77% | |
| PolyPid | 71% | |
OncoLize Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 14, 2023 |
Key People
Founding team and executive leadership
OncoLize Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Libertatis Ergo Holding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2023
$1.7M round led by Libertatis Ergo Holding
OncoLize Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncoLize's valuation, stock price, and market status.